PER
Click for more information
1.23% 8.0¢ percheron therapeutics limited

re: Ann: Change of Director's Interest No... Agreed, rare stuff...

  1. Moreforme
    4,633 Posts.
    lightbulb Created with Sketch. 694
    clock Created with Sketch.
    14/05/13
    15:18
    Post #: 11761977
    re: Ann: Change of Director's Interest No... Agreed, rare stuff really lets both the company and technology [hopefully] shine. Obviously, for example, another blood pressure pill is not going to add serious value to a new bio-tech - you've gotta go into new higher return space - once the technology matures it will naturally gravitate to more "traditional" areas.....

    Just my totally unfounded views ;) DYOR
    ANP Price at posting: 10.0¢ Sentiment: LT Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
NEWS ASX hits all time high out the gate on Friday trades following bullish US inflation data
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢ 		Change
-0.001(1.23%) 		Mkt cap ! $72.12M
Open High Low Value Volume
8.2¢ 8.2¢ 8.0¢ $63.52K 777.8K

Buyers (Bids)

No. Vol. Price($)
2 43377 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 97561 1
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.